197 related articles for article (PubMed ID: 8943674)
1. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
[TBL] [Abstract][Full Text] [Related]
2. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
[TBL] [Abstract][Full Text] [Related]
3. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
[TBL] [Abstract][Full Text] [Related]
4. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
5. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
6. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
[TBL] [Abstract][Full Text] [Related]
7. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
8. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
[TBL] [Abstract][Full Text] [Related]
9. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
[TBL] [Abstract][Full Text] [Related]
10. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group.
Bjordal K; Ahlner-Elmqvist M; Tollesson E; Jensen AB; Razavi D; Maher EJ; Kaasa S
Acta Oncol; 1994; 33(8):879-85. PubMed ID: 7818919
[TBL] [Abstract][Full Text] [Related]
11. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E; Yadegarfar G; Byrne C; Johnson CD; Sezer O; Pucciarelli S; Pereira SP; Chie WC; Banfield A; Ramage JK;
Br J Cancer; 2011 Feb; 104(4):587-92. PubMed ID: 21266979
[TBL] [Abstract][Full Text] [Related]
12. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.
Straatman J; Joosten PJ; Terwee CB; Cuesta MA; Jansma EP; van der Peet DL
Dis Esophagus; 2016 Oct; 29(7):760-772. PubMed ID: 26471471
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of quality of life measures for patients with esophageal cancer.
Blazeby JM; Kavadas V; Vickery CW; Greenwood R; Berrisford RG; Alderson D
Qual Life Res; 2005 Mar; 14(2):387-93. PubMed ID: 15892427
[TBL] [Abstract][Full Text] [Related]
15. Quality of life measurement in patients with oesophageal cancer.
Blazeby JM; Williams MH; Brookes ST; Alderson D; Farndon JR
Gut; 1995 Oct; 37(4):505-8. PubMed ID: 7489936
[TBL] [Abstract][Full Text] [Related]
16. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
[TBL] [Abstract][Full Text] [Related]
17. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
[TBL] [Abstract][Full Text] [Related]
18. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
19. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
[TBL] [Abstract][Full Text] [Related]
20. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
